Skip to main content
Year archive

Rakovina Therapeutics Inc. — 2023 filings

All 42 regulatory filings released by Rakovina Therapeutics Inc. (RKV) in 2023, sourced directly from the official regulator.

42 Filings
2023 Period
2023 filings (42)
Filing Released Lang
Report of exempt distribution (45-106F1).pdf
Regulatory Filings
2023-12-14 English
News release - English.pdf
Interim / Quarterly Report Q3 2023
2023-11-28 English
52-109FV2 - Certification of interim filings - CFO (E).pdf
Regulatory Filings
2023-11-28 English
52-109FV2 - Certification of interim filings - CEO (E).pdf
Regulatory Filings
2023-11-28 English
Interim MD&A - English.pdf
Interim / Quarterly Report 9M 2023
2023-11-28 English
Interim financial statements/report – English.pdf
Interim / Quarterly Report 9M 2023
2023-11-28 English
News release - English.pdf
Regulatory Filings
2023-11-27 English
News release - English.pdf
Regulatory Filings
2023-11-20 English
52-109FV2 - Certification of interim filings - CFO (E).pdf
Regulatory Filings
2023-08-29 English
Interim MD&A - English.pdf
Regulatory Filings
2023-08-29 English
Interim financial statements/report – English.pdf
Regulatory Filings
2023-08-29 English
News release - English.pdf
Regulatory Filings
2023-08-29 English
News release - English.pdf
Audit Report / Information FY 2023
2023-06-29 English
Report of exempt distribution excluding schedule 1 of Form 5.pdf
Regulatory Filings
2023-06-08 English
Material change report - English.pdf
Regulatory Filings
2023-06-06 English
Other.pdf
Regulatory Filings
2023-06-06 English
Other.pdf
Regulatory Filings
2023-06-01 English
Form of proxy - English.pdf
Proxy Solicitation & Information Statement
2023-06-01 English
Notice of meeting - English.pdf
AGM Information
2023-06-01 English
Management information circular - English.pdf
AGM Information
2023-06-01 English
News release - English.pdf
Regulatory Filings
2023-05-31 English
52-109FV2 - Certification of interim filings - CEO (E).pdf
Regulatory Filings
2023-05-31 English
52-109FV2 - Certification of interim filings - CFO (E).pdf
Regulatory Filings
2023-05-31 English
Interim MD&A - English.pdf
Interim / Quarterly Report Q1 2023
2023-05-31 English
Interim financial statements/report – English.pdf
Interim / Quarterly Report Q1 2023
2023-05-31 English
News release - English.pdf
Capital/Financing Update
2023-05-30 English
News release - English.pdf
Annual Report FY 2022
2023-05-02 English
Annual information form - English.pdf
Regulatory Filings
2023-05-02 English
52-109FV1 - Certification of annual filings - CEO (E).pdf
Regulatory Filings
2023-04-29 English
52-109FV1 - Certification of annual filings - CFO (E).pdf
Regulatory Filings
2023-04-29 English
Annual MD&A - English.pdf
Regulatory Filings
2023-04-29 English
AB form 13-501F1 (class 1 and 3B reporting issuers - participation fee).pdf
Regulatory Filings
2023-04-29 English
ON form 13-502F1 (class 1 and 3B reporting issuers - participation fee).pdf
Regulatory Filings
2023-04-29 English
Audited annual financial statements – English.pdf
Audit Report / Information FY 2022
2023-04-29 English
Notice of the meeting and record date - English.pdf
AGM Information
2023-04-28 English
News release - English.pdf
Regulatory Filings
2023-04-20 English
News release - English.pdf
Investor Presentation
2023-04-18 English
News release - English.pdf
Capital/Financing Update
2023-03-30 English
News release - English.pdf
Capital/Financing Update
2023-03-24 English
News release - English.pdf
Capital/Financing Update
2023-03-22 English
News release - English.pdf
Capital/Financing Update
2023-03-11 English
News release - English.pdf
Regulatory Filings
2023-01-27 English